October 24, 2016 3:09 AM ET


Company Overview of Triangle Pharmaceuticals, Inc.

Company Overview

As of January 16, 2003, Triangle Pharmaceuticals, Inc. was acquired by Gilead Sciences, Inc. Triangle Pharmaceuticals, Inc. develops new drug candidates primarily in the antiviral area, with a particular focus on therapies for HIV, including AIDS, and the hepatitis B virus. Its portfolio consists of several licensed drug candidates in clinical trials and others that are in a preclinical stage. The company's drug candidates include Coviracil (emtricitabine), a potent nucleoside reverse transcriptase inhibitor in Phase III testing for the treatment of HIV; Amdoxovir, a guanosine nucleoside analogue for the treatment of HIV; and Clevudine, a novel pyrimidine nucleoside analogue for the treatmen...

4 University Place

4611 University Drive

Durham, NC 27707

United States

115 Employees



Key Executives for Triangle Pharmaceuticals, Inc.

Triangle Pharmaceuticals, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Triangle Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.